ATE79031T1 - Verwendung von ketonderivaten zur behandlung von depressionen. - Google Patents

Verwendung von ketonderivaten zur behandlung von depressionen.

Info

Publication number
ATE79031T1
ATE79031T1 AT87311082T AT87311082T ATE79031T1 AT E79031 T1 ATE79031 T1 AT E79031T1 AT 87311082 T AT87311082 T AT 87311082T AT 87311082 T AT87311082 T AT 87311082T AT E79031 T1 ATE79031 T1 AT E79031T1
Authority
AT
Austria
Prior art keywords
ketone derivatives
treat depression
methyl
depression
treat
Prior art date
Application number
AT87311082T
Other languages
English (en)
Inventor
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE79031T1 publication Critical patent/ATE79031T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Connection Of Batteries Or Terminals (AREA)
  • Saccharide Compounds (AREA)
  • Electrotherapy Devices (AREA)
AT87311082T 1986-12-17 1987-12-16 Verwendung von ketonderivaten zur behandlung von depressionen. ATE79031T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868630071A GB8630071D0 (en) 1986-12-17 1986-12-17 Medicaments
EP87311082A EP0276559B1 (de) 1986-12-17 1987-12-16 Verwendung von Ketonderivaten zur Behandlung von Depressionen

Publications (1)

Publication Number Publication Date
ATE79031T1 true ATE79031T1 (de) 1992-08-15

Family

ID=10609112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87311082T ATE79031T1 (de) 1986-12-17 1987-12-16 Verwendung von ketonderivaten zur behandlung von depressionen.

Country Status (18)

Country Link
US (1) US4835173A (de)
EP (1) EP0276559B1 (de)
JP (1) JP2732844B2 (de)
KR (1) KR880007073A (de)
AT (1) ATE79031T1 (de)
AU (1) AU608794B2 (de)
CY (1) CY1693A (de)
DE (1) DE3780940T2 (de)
DK (1) DK662787A (de)
ES (1) ES2051754T3 (de)
GB (1) GB8630071D0 (de)
GR (1) GR3005682T3 (de)
HK (1) HK36593A (de)
IE (1) IE60135B1 (de)
IL (1) IL84844A0 (de)
NZ (1) NZ222949A (de)
PH (1) PH25503A (de)
ZA (1) ZA879458B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973594A (en) * 1986-12-17 1990-11-27 Glaxo Group Limited Medicaments
US5246941A (en) 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
US5221687A (en) * 1988-09-01 1993-06-22 Glaxo Group Limited Medicaments
GB8820653D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
US5180728A (en) * 1989-09-25 1993-01-19 Fujisawa Pharmaceutical Company, Ltd. Pyrimidoindole derivatives and processes for preparation thereof
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
EP0591434A4 (en) * 1991-06-26 1994-09-14 Sepracor Inc Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
US6548082B1 (en) 1999-03-01 2003-04-15 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
WO2002036558A2 (en) * 2000-10-30 2002-05-10 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
EP1207160A1 (de) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Verfahren zur Herstellung von 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
MXPA03006215A (es) * 2001-01-11 2005-02-17 Teva Pharma Un proceso mejorado para preparar clorhidrato de ondansetron dihidratado puro.
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
DK1499623T3 (da) * 2002-04-29 2007-10-08 Teva Gyogyszerg Ar Zartkoeruee Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on
EP1465887A1 (de) * 2002-04-30 2004-10-13 Teva Gyogyszergyar Reszvenytarsasag Neue kristallformen von ondansetron, verfahren zu deren herstellung, diese enthaltende arzneimittel und verfahren zur behandlung von übelkeit damit [1983/18]
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
HU225885B1 (en) * 2002-10-17 2007-11-28 Richter Gedeon Nyrt Process for producing ondansetron hydrochlorid dihydrate of high purity
EP2186517A4 (de) * 2007-08-08 2010-08-18 Ibanez Juan Jose Legarda Verwendung und anwendungsverfahren für einen serotin3-rezeptor (5-ht3)-antagonisten und selektiven chloridkanalmodulator zur behandlung von sucht bzw. abhängigkeit von arzneimitteln/drogen oder erkrankungen des nervensystems
CA3099624A1 (en) * 2018-06-21 2019-12-26 Societe Des Produits Nestle S.A. Compositions and methods using a nicotinamide adenine dinucleotide (nad+) precursor and at least one ketone or ketone precursor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN158970B (de) * 1981-06-09 1987-02-28 Ici Plc
ES8609309A1 (es) * 1984-01-25 1986-07-16 Glaxo Group Ltd Un nuevo procedimiento para la preparacion de nuevos derivados. de carbazolona.
GB8401888D0 (en) * 1984-01-25 1984-02-29 Glaxo Group Ltd Heterocyclic compounds
DE385517T1 (de) * 1985-03-14 1991-07-25 Beecham Group P.L.C., Brentford, Middlesex, Gb Arzneimittel zur behandlung von erbrechen.
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
HU895334D0 (en) * 1986-07-30 1990-01-28 Sandoz Ag Process for the preparation of nasal pharmaceutical compositions

Also Published As

Publication number Publication date
CY1693A (en) 1994-01-14
ES2051754T3 (es) 1994-07-01
PH25503A (en) 1991-07-24
DK662787A (da) 1988-06-18
IE873415L (en) 1988-06-17
JPS63165314A (ja) 1988-07-08
IE60135B1 (en) 1994-06-01
DE3780940T2 (de) 1992-12-24
KR880007073A (ko) 1988-08-26
DE3780940D1 (de) 1992-09-10
ZA879458B (en) 1988-11-30
GR3005682T3 (de) 1993-06-07
AU608794B2 (en) 1991-04-18
EP0276559A3 (en) 1989-10-18
HK36593A (en) 1993-04-23
US4835173A (en) 1989-05-30
GB8630071D0 (en) 1987-01-28
EP0276559B1 (de) 1992-08-05
IL84844A0 (en) 1988-06-30
JP2732844B2 (ja) 1998-03-30
DK662787D0 (da) 1987-12-16
AU8261787A (en) 1988-06-23
EP0276559A2 (de) 1988-08-03
NZ222949A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
ATE79031T1 (de) Verwendung von ketonderivaten zur behandlung von depressionen.
SE8503680L (sv) Indolderivat
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69022249D1 (de) Knochenwachsapplikator zur Behandlung von Knochengewebe.
DE69521620T2 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DE3784693D1 (de) Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.
FI913818A0 (fi) Nytt trombolytiskt aemne.
ATE222491T1 (de) Melatonin-derivate zur verwendung in der behandlung von schlafstörungen
ATE96317T1 (de) Verwendung von 5-(subst. phenyl)oxazolidinonderivaten zur behandlung von depressionen.
ATE70181T1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
DE69113773D1 (de) Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma.
ATE136463T1 (de) Verwendung von 1,2,3,4-tetrahydroacridinen zur behandlung von aids, sowie verbindungen
NO972450L (no) Substituerte 2-(fosfinyloksymetyl)-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metode for anvendelse derav
DE69022027D1 (de) 2-Alkyl-3-benzoylbenzofurane zur Behandlung von Herzarrhythmia.
DE68907433T2 (de) Verwendung von Dimetylheptylphenylbutanoylethanolamin bei der Behandlung von Hyperuricemie.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE299021T1 (de) Verwendung von oxazolidinonderivaten zur behandlung von psoriasis
DE69001070D1 (de) Verwendung von beta-blockierungsmitteln zur behandlung der meniere-krankheit.
IT8722869V0 (it) Dispositivo perfezionato per l'abbronzatura artificiale integrale o parziale.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DE3771706D1 (de) Behandlung von knochenschwund.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee